Novartis

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novartis and other ETFs, options, and stocks.

About NVS

Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. 

CEO
Vasant Narasimhan
CEOVasant Narasimhan
Employees
76,057
Employees76,057
Headquarters
Basel, Basel-Stadt (Basle Town)
HeadquartersBasel, Basel-Stadt (Basle Town)
Founded
1996
Founded1996
Employees
76,057
Employees76,057

NVS Key Statistics

Market cap
212.76B
Market cap212.76B
Price-Earnings ratio
13.41
Price-Earnings ratio13.41
Dividend yield
2.37%
Dividend yield2.37%
Average volume
1.51M
Average volume1.51M
High today
$97.20
High today$97.20
Low today
$96.16
Low today$96.16
Open price
$96.29
Open price$96.29
Volume
1.52M
Volume1.52M
52 Week high
$108.78
52 Week high$108.78
52 Week low
$85.12
52 Week low$85.12

NVS News

Yahoo Finance 16h
Investors Heavily Search Novartis AG: Here is What You Need to Know - Yahoo Finance

Novartis (NVS) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's pe...

Investors Heavily Search Novartis AG: Here is What You Need to Know - Yahoo Finance
Yahoo Finance 1d
Novartis Increases Yet Falls Behind Market: What Investors Need to Know - Yahoo Finance

Novartis (NVS) closed at $95.88 in the latest trading session, marking a +0.64% move from the prior day. The stock trailed the S&P 500, which registered a daily...

Novartis Increases Yet Falls Behind Market: What Investors Need to Know - Yahoo Finance
Benzinga 4d
Magnificent 7 Stocks Become The Star Attractions For Norway's Sovereign Wealth Fund

Loading... Loading... If anyone needs any proof of how the landscape of investment has changed as a result of a handful of technology companies over the past d...

Magnificent 7 Stocks Become The Star Attractions For Norway's Sovereign Wealth Fund

Analyst ratings

52%

of 25 ratings
Buy
36%
Hold
52%
Sell
12%

More NVS News

TipRanks 7d
MorphoSys Set for Novartis Takeover Post-U.S. Clearance - TipRanks.com - TipRanks

Morphosys (MOR) has released an update. MorphoSys AG has announced receiving U.S. antitrust clearance for its acquisition by Novartis AG, satisfying all mandat...

Yahoo Finance 7d
MorphoSys Announces U.S. Antitrust Clearance of Proposed Acquisition by Novartis Under HSR Act - Yahoo Finance

PLANEGG and MUNICH, GERMANY / ACCESSWIRE / March 22, 2024 / MorphoSys AG (FSE:MOR)(NASDAQ:MOR) today announced the receipt of U.S. antitrust clearance under the...

MorphoSys Announces U.S. Antitrust Clearance of Proposed Acquisition by Novartis Under HSR Act - Yahoo Finance
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.